Uncategorized

During cancer treatment, many patients may receive the same therapy yet experience markedly different responses and levels of tolerance.
Research suggests that these differences are not solely related to the tumor itself, but are also closely linked to the patient’s overall physiological condition. One key indicator is albumin (Human Serum Albumin, HSA).

Multiple studies have shown that low albumin levels are significantly associated with higher rates of treatment interruption, increased risk of complications, and poorer overall prognosis in cancer patients (McMillan, 2001; Gupta & Lis, 2010).

For many cancer patients, an important concern beyond standard treatments is whether there are additional approaches that can suppress cancer cell growth through different biological pathways. In recent years, high-dose vitamin C (high-dose vitamin C) has frequently appeared in patient communities and scientific literature, sparking widespread discussion.

For many breast cancer patients, fighting cancer is not simply about completing a treatment protocol. It is a long-term battle that consumes both physical strength and emotional resilience. Even after surgery, chemotherapy, radiotherapy, targeted therapy, or hormonal therapy, many patients continue to struggle with fatigue, weakened immunity, recurrent infections, and a noticeable decline in quality of life.

For cancer patients, fighting cancer has never been merely a battle to “eliminate cancer cells completely.” Increasingly, patients come to realize during treatment that what truly influences disease progression is the body’s overall condition—especially whether the immune system can withstand long-term stress.

For many cancer patients, while undergoing surgery, chemotherapy, targeted therapy, or immunotherapy, a persistent question remains: Are there other approaches that can help the body fight cancer, reduce side effects, or even enhance treatment outcomes?

For cancer patients, fighting cancer has never been a one-way path. As treatment experiences accumulate, more patients come to realize that cancer progression is not determined solely by the tumor itself, but is closely linked to the body’s metabolic state, immune response, oxidative stress, and tumor microenvironment.